Monitoring changes in malaria epidemiology and effectiveness of interventions in Ethiopia and Uganda: Beyond Garki Project baseline survey

listen audio

Study Justification:
The study aims to monitor changes in malaria epidemiology and the effectiveness of interventions in Ethiopia and Uganda. This is important because while the scale-up of malaria interventions has contributed to a decline in the disease, other factors may also play a role. Understanding these changes and determining the factors involved will help in adapting control strategies accordingly.
Highlights:
– The study collected data on malariometric and entomological variables, socio-economic status, and control coverage in four sites in Ethiopia and Uganda.
– Malaria prevalence varied between the sites, with the most dominant species being Plasmodium vivax in Ethiopia and Plasmodium falciparum in Uganda.
– The study found that the majority of human-vector contact occurred indoors in Uganda, which is important for the effectiveness of insecticide-treated nets (ITNs) or indoor residual spraying (IRS).
– High levels of insecticide resistance were observed in Anopheles gambiae sensu stricto in Uganda.
– ITN ownership did not vary by socio-economic status, and a high percentage of households owned at least one ITN in both Ethiopia and Uganda.
– In three of the four sites, a high percentage of people with access to ITNs used them.
– IRS coverage ranged from 84 to 96% in the three sprayed sites.
– Diagnostic tests were sought for half of febrile children in Uganda and three-quarters in Ethiopia.
– High levels of child undernutrition were detected in both countries.
– In Uganda, a low percentage of pregnant women took the recommended minimum three doses of intermittent preventive treatment.
Recommendations:
– Regular monitoring is essential to better interpret changes in malaria epidemiology and identify determinants.
– Strategies should be modified and improved targeting should be implemented to address transmission heterogeneity.
Key Role Players:
– Researchers and scientists
– Health officials and policymakers
– Community leaders and volunteers
– Healthcare providers
– Laboratory technicians
– Data analysts and statisticians
Cost Items for Planning Recommendations:
– Research and data collection equipment
– Personnel salaries and training
– Laboratory supplies and equipment
– Transportation and logistics
– Communication and dissemination of findings
– Monitoring and evaluation activities
– Community engagement and awareness campaigns
– Data analysis and reporting

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is strong, but there are some areas for improvement. The abstract provides detailed information about the study design, data collection methods, and key findings. However, it lacks information on the sample size and representativeness of the study population. To improve the evidence, the abstract should include information on the sample size and how the study population was selected to ensure that the findings are generalizable. Additionally, it would be helpful to include information on the statistical methods used to analyze the data and determine the significance of the findings.

Background: Scale-up of malaria interventions seems to have contributed to a decline in the disease but other factors may also have had some role. Understanding changes in transmission and determinant factors will help to adapt control strategies accordingly. Methods: Four sites in Ethiopia and Uganda were set up to monitor epidemiological changes and effectiveness of interventions over time. Here, results of a survey during the peak transmission season of 2012 are reported, which will be used as baseline for subsequent surveys and may support adaptation of control strategies. Data on malariometric and entomological variables, socio-economic status (SES) and control coverage were collected. Results: Malaria prevalence varied from 1.4 % in Guba (Ethiopia) to 9.9 % in Butemba (Uganda). The most dominant species was Plasmodium vivax in Ethiopia and Plasmodium falciparum in Uganda. The majority of human-vector contact occurred indoors in Uganda, ranging from 83 % (Anopheles funestus sensu lato) to 93 % (Anopheles gambiae s.l.), which is an important factor for the effectiveness of insecticide-treated nets (ITNs) or indoor residual spraying (IRS). High kdr-L1014S (resistance genotype) frequency was observed in A. gambiae sensu stricto in Uganda. Too few mosquitoes were collected in Ethiopia, so it was not possible to assess vector habits and insecticide resistance levels. ITN ownership did not vary by SES and 56-98 % and 68-78 % of households owned at least one ITN in Ethiopia and Uganda, respectively. In Uganda, 7 % of nets were purchased by households, but the nets were untreated. In three of the four sites, 69-76 % of people with access to ITNs used them. IRS coverage ranged from 84 to 96 % in the three sprayed sites. Half of febrile children in Uganda and three-quarters in Ethiopia for whom treatment was sought received diagnostic tests. High levels of child undernutrition were detected in both countries carrying important implications on child development. In Uganda, 7-8 % of pregnant women took the recommended minimum three doses of intermittent preventive treatment. Conclusion: Malaria epidemiology seems to be changing compared to earlier published data, and it is essential to have more data to understand how much of the changes are attributable to interventions and other factors. Regular monitoring will help to better interpret changes, identify determinants, modify strategies and improve targeting to address transmission heterogeneity.

A ‘study site’ in the context of the project is defined as a ‘health centre and the catchment population in selected villages around it’. Two study sites were selected per country in Ethiopia and Uganda, representing different epidemiological settings in rural environments (Table 1). Beyond Garki study sites in Uganda and Ethiopia SNNP Southern Nations, Nationalities and Peoples The selection of the study sites was based on the need to represent different epidemiological (transmission) settings, geographical location and accessibility, and availability of adequate baseline morbidity data. The four study sites represented settings ranging from low seasonal transmission in the Ethiopia sites to high perennial transmission in the Uganda sites. Only villages in close proximity to the health centres were selected, covering a radius of approximately 2–6 kms to reduce potential bias in the analysis of treatment-seeking and use of services by the study population. Most areas below 2000 m above sea level are considered malarious in Ethiopia. An estimated 60 % of the population live in areas at risk of malaria transmission [13]. Both Plasmodium falciparum and Plasmodium vivax are common. The Malaria Indicator Survey (MIS) during October-December 2011 showed that nationally the prevalence of malaria was 1.3 % in areas below 2000 m; 77 % of the positive slides were P. falciparum infections [14]. There is marked seasonality in transmission and geographic variation in intensity. Many areas are epidemic-prone. Anopheles arabiensis is the main vector species [15]. Anopheles pharoensis, Anopheles funestus and Anopheles nili are considered secondary vectors. Resistance of the main vector against DDT and pyrethroids is widespread in the country [16]. Ethiopia’s organized malaria control began in 1959 when the Malaria Eradication Service was established a year after a major epidemic claimed an estimated 150,000 lives [17]. A blanket DDT spraying campaign was used until the early 1970s, when the eradication strategy was abandoned and replaced with a control programme [18]. The programme, based on selective spraying and treatment of cases, continued until the mid-1990s after which the specialized service was gradually integrated into the general health services. There has been a substantial increase in coverage of key interventions in the country. More than 64 million long-lasting insecticidal nets (LLINs) were distributed through mass campaigns between 2005 and 2014 [13]. IRS is also implemented in many areas. Through the expansion of basic health services, mainly health posts, diagnostic and treatment services have increased over the years. Malaria is highly endemic in approximately 95 % of the country where 90 % of the population live. The MIS in November and December 2009 reported that 42 % of children under the age of five tested positive for malaria with microscopic diagnosis [19]. Plasmodium falciparum is responsible for 99 % of malaria cases. The disease accounts for 25–40 % outpatient visits and nearly half of inpatient paediatric deaths [20]. The main malaria vectors are Anopheles gambiae s.s., A. arabiensis and A. funestus [19, 20]. Although IRS was implemented in limited sites as part of the WHO pilot programme between 1959 and 1963, the operation was not scaled up [21]. Treatment of cases remained the only malaria control measure for many years. The Malaria Control Unit was established in 1995 and grew into the National Malaria Control Programme. The main preventive interventions in Uganda are LLINs, IRS in selected districts, and intermittent preventive treatment in pregnancy (IPTp). Uganda has scaled up effective case management and in some regions village health teams (VHTs) were trained to test and treat common childhood illnesses including malaria through Integrated Community Case Management (ICCM). In 2009, 47 % of households owned at least one insecticide-treated net (ITN) compared to 16 % in 2006 [19, 22]; this increased to 60 % in 2011 [23]. These combined efforts are believed to have resulted in reduced transmission in many areas [24]. Up to 10 districts in northern Uganda have been sprayed in the past 6–7 years within the IRS programme supported by the US Government’s Presidential Malaria Initiative (PMI) [20]. Starting from 2014, more northern and eastern districts were added while the operation ended in others (including Apac, the district containing the study site Aduku) due to a decline in transmission. A large reduction in malaria prevalence was observed in children living in sprayed areas compared to those living in unsprayed areas [25]. Meanwhile, more than 21 million LLINs were distributed in a nation-wide mass campaign during 2012–2014. Repeat cross-sectional surveys were conducted in the selected sites (of which only results from the first study are presented here as the baseline data). The study also included longitudinal collection of meteorological and morbidity data at health facilities. The main components include: household surveys, malariometric and serological surveys, entomological surveys, health facility-based morbidity studies, and climatic studies. For the household surveys, the required sample size was estimated for each site by assuming 5 and 50 % baseline prevalence in children below 10 years in Ethiopia and Uganda, respectively. All households in villages around each health centre (within radius of 2–6 kms) were enumerated and included in the sampling frame. A simple random sample of 571 and 234 households were selected in each site in Ethiopia and Uganda, respectively. The sample sizes were determined separately for the two countries based on expected malaria prevalence rates, household sizes and a 10 % non-response rate using appropriate statistical procedures, and sample sizes for each site were calculated independently assuming simple random sampling. The household surveys included interviews with household heads and women aged 15–49 years of age using handheld devices (smartphones with Pendragon Forms 5.1 or tablets with Open Data Kit). Data were collected on variables indicating socio-economic status (SES), prevention methods, knowledge about malaria, ITN ownership and use, as well as number of children born to interviewed women who were alive and dead, febrile illness in children, treatment sought and protection against malaria during pregnancy. Each member of the sampled households (except infants under 6 months) was given a subject card and asked to visit a malariometric testing site within the village to obtain anthropometric measurements and collect blood samples. Bodyweight, temperature, height and mid-upper arm circumference were measured for children under five. Thick and thin blood films for microscopy, dry blood spots for serology and blood samples for haemoglobin measurement using the HemoCue machine (Hb 301, Ängelholm, Sweden) were obtained for all subjects. RDTs (CareStart™ pf-HRP2/pan-pLDH by Access Bio USA in Ethiopia and SD Bioline in Uganda) were used to test subjects with body temperature 37.5 °C and above or history of fever in the previous 48 h. Individuals with fever or history of fever were tested by RDT for the purpose of providing anti-malarial treatment. Treatment was provided at the field site according to national guidelines for mild and moderate anaemia (using ferrous sulphate) and uncomplicated malaria cases (using artemether–lumefantrine for P. falciparum and chloroquine for P. vivax), while severe cases were referred to the site’s health centre. Slides were stained with Giemsa and examined by two independent microscopists for presence/absence of asexual parasites and gametocytes and species identification. In the case of discrepant results, a third microscopist examined the slides for a final verification. Serological analysis of dry blood spots from the Uganda sites was carried out to determine antibody responses to assess malaria transmission intensity over an extended period of time. The antibody response of individuals against merozoite surface protein-119 (MSP-119) was determined using an enzyme-linked immunosorbent assay (ELISA). Serum obtained from the dried blood spots on filter papers was analysed at the Medical Research Council (MRC) Laboratory in Uganda for total IgG antibodies using P. falciparum antigen MSP-119 (CTK Biotech, USA, cat. No. A3003) following previously described methods [26, 27]. Anopheles mosquitoes were sampled to determine species composition, densities, behaviour and insecticide resistance using light trap collection, exit trap collection, room search, pyrethrum spray catch and human landing catch (HLC) in 12 houses per site selected using simple random sampling from the sampling frame for the household survey. Mosquitoes were identified using morphological features and individually packed in microtubes for molecular analysis, which were carried out at Rothamsted Research in the UK [28]. Genomic DNA was extracted using the Livak method. A. gambiae s.l. samples were analysed to determine whether they were A. gambiae s.s. or A. arabiensis [29, 30]. Anopheles gambiae s.l. samples were analysed mainly for knock down resistance (kdr) mutations (but also for mutation in the ace-1 gene which encodes the acetylcholinesterase enzyme although not reported here) [31]. Other components of the study not reported in the present paper include: use of automatic weather stations (BWS200 automatic weather station, Campbell Scientific, Stellenbosch, South Africa) installed in all sites to record hourly meteorological data, compilation of outpatient morbidity data for every suspected or confirmed malaria patient seen at the health facility in each site, and mathematical modelling of transmission. Ethical clearance was obtained from the appropriate review boards (Uganda: UNCST 1348; Ethiopia: 3-10/819/05). In addition, written consent was obtained from respondents for interviews, for all subjects that participated in malariometric surveys, and from household heads for entomology sentinel houses. EpiData v3.1 (The EpiData Association, Odense, Denmark) was used for data entry where necessary. Stata versions 12 and 13 (StataCorp LP, College Station, TX, USA) and Microsoft Excel (Microsoft Corporation) were used for data analysis. Chi squared tests were used where appropriate to assess significant differences between groups of interest, taking into account clustering at household level. Principal components analysis (PCA) was used to calculate wealth index for each household, computed separately for each country. Infection prevalence data were analysed in relation to potential household or individual risk factors such as coverage and use of prevention methods, housing conditions, demographic factors and socio-economic status. Undernutrition was studied using the anthropometric data for children under five. A Stata program file ZSCORE06 developed by Jef Leroy (Boston College Department of Economics) was used to calculate anthropometric z-scores using the 2006 WHO Child Growth Standards [32]. Anaemia was classified as mild, moderate or severe based on the concentrations of haemoglobin (Hb) as follows; (a) mild anaemia: for non-pregnant women, Hb 10.0–11.9 g/dl; for pregnant women and children under 5, Hb 10.0–10.9 g/dl; for men: Hb 10.0–12.9 g/dl; (b) moderate anaemia: Hb 7.0–9.9 g/dl; c) severe anaemia: Hb <7.0 g/dl [33]. Optical density (OD) values were analysed in Microsoft Excel using a macro file provided by C. Drakeley, London School of Hygiene and Tropical Medicine (LSHTM). Normalized OD values were used for data analysis using a Stata procedure provided by C. Drakeley (LSHTM). A cut-off value of 0.177 was used to determine seropositive samples. Age seroprevelance curves were generated using methods described by Corran et al. [34]. Data for children below 2 years was excluded to avoid potential bias caused by maternal antibodies [35]. A variant of the Brass indirect method [36] was used to calculate under-five mortality rate (U5MR) using the summary birth history dataset provided by women of child-bearing age which included age of mother, total number of live births and total number of deaths [37]. Mortality rates were not calculated for the 3 years period before the survey date (2009–2012), namely data related to women aged 15–19, because of the selection effect where women from lower socioeconomic classes tend to start childbearing early and their children face above average mortality risks [38]; and because random errors are larger for estimates based on the reports of young women, since they have fewer children ever born. Various entomological parameters were estimated including species compositions, and indoor resting and biting habits. Human biting rates (i.e., the number of bites per person per night) were calculated taking into account the number of collectors working simultaneously, the number of collection nights, and the assumed night-time behaviour of the local human populations. It was assumed that an average villager in each of the sites spends 1 h on average outdoors between 18:00 h and 22:00 h, and all villagers are indoors after 22:00 h.

Based on the provided information, here are some potential innovations that could improve access to maternal health:

1. Mobile health clinics: Implementing mobile health clinics that can travel to remote areas and provide maternal health services, including prenatal care, delivery assistance, and postnatal care.

2. Telemedicine: Utilizing telemedicine technology to connect pregnant women in remote areas with healthcare professionals who can provide virtual consultations, monitor their health, and offer guidance and support.

3. Community health workers: Training and deploying community health workers who can provide basic maternal health services, education, and support to pregnant women in their communities.

4. Maternal health vouchers: Introducing a voucher system that provides pregnant women with access to essential maternal health services, such as prenatal care, delivery assistance, and postnatal care, at reduced or no cost.

5. Maternal health awareness campaigns: Launching targeted awareness campaigns to educate pregnant women and their families about the importance of maternal health, the available services, and how to access them.

6. Transportation support: Providing transportation support, such as ambulances or transportation vouchers, to pregnant women in remote areas to ensure they can reach healthcare facilities for prenatal care, delivery, and postnatal care.

7. Strengthening healthcare infrastructure: Investing in improving healthcare infrastructure in remote areas, including the construction and staffing of maternal health clinics and hospitals, to ensure access to quality maternal healthcare services.

8. Maternal health financing schemes: Implementing innovative financing schemes, such as microinsurance or community-based health financing, to make maternal health services more affordable and accessible for pregnant women in remote areas.

9. Maternal health information systems: Developing and implementing information systems that can track and monitor maternal health indicators in real-time, allowing for timely interventions and improvements in service delivery.

10. Partnerships and collaborations: Encouraging partnerships and collaborations between government agencies, non-profit organizations, and private sector entities to pool resources, expertise, and knowledge to improve access to maternal health services in remote areas.
AI Innovations Description
Based on the information provided, here is a recommendation that can be used to develop an innovation to improve access to maternal health:

1. Implement targeted interventions: Based on the findings of the study, it is important to develop and implement targeted interventions to address the specific challenges identified in each study site. For example, in areas with high malaria prevalence, interventions such as distribution of insecticide-treated nets (ITNs) and indoor residual spraying (IRS) should be prioritized to reduce malaria transmission and protect pregnant women from infection.

2. Improve access to diagnostic testing: The study found that only half of febrile children in Uganda and three-quarters in Ethiopia received diagnostic tests for malaria. To improve access to maternal health, it is crucial to ensure that all pregnant women have access to diagnostic testing for malaria. This can be achieved by strengthening health systems, training healthcare providers, and ensuring the availability of diagnostic tools in all healthcare facilities.

3. Enhance antenatal care services: The study revealed that a low percentage of pregnant women in Uganda received the recommended minimum three doses of intermittent preventive treatment (IPTp) for malaria. To improve access to maternal health, antenatal care services should be strengthened to ensure that all pregnant women receive the necessary interventions to prevent and treat malaria, such as IPTp and access to ITNs.

4. Address undernutrition: The study detected high levels of child undernutrition in both Ethiopia and Uganda, which can have significant implications for child development and maternal health. To improve access to maternal health, interventions to address undernutrition should be integrated into existing maternal and child health programs. This can include providing nutritional counseling, promoting breastfeeding, and ensuring access to nutritious food for pregnant women and young children.

5. Regular monitoring and evaluation: The study emphasizes the importance of regular monitoring to better understand changes in malaria epidemiology and the effectiveness of interventions. To improve access to maternal health, it is crucial to establish a robust monitoring and evaluation system to track progress, identify gaps, and inform decision-making. This can include regular data collection, analysis, and reporting on key maternal health indicators.

By implementing these recommendations, it is possible to develop innovative approaches to improve access to maternal health, reduce the burden of malaria, and enhance the overall well-being of pregnant women and their children.
AI Innovations Methodology
Based on the provided information, here are some potential recommendations to improve access to maternal health:

1. Strengthening healthcare infrastructure: Investing in the improvement of healthcare facilities, particularly in rural areas, can help increase access to maternal health services. This includes ensuring the availability of skilled healthcare providers, essential medical equipment, and necessary supplies.

2. Community-based interventions: Implementing community-based interventions, such as training and empowering local community health workers, can improve access to maternal health services. These workers can provide basic prenatal care, education, and referrals to pregnant women in remote areas.

3. Mobile health (mHealth) solutions: Utilizing mobile technology to deliver maternal health information and services can help overcome geographical barriers. Mobile apps, SMS reminders, and telemedicine consultations can provide pregnant women with access to vital information and support.

4. Financial incentives: Providing financial incentives, such as conditional cash transfers or subsidies, can encourage pregnant women to seek and utilize maternal health services. This can help overcome financial barriers that may prevent women from accessing necessary care.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could include the following steps:

1. Define indicators: Identify key indicators that measure access to maternal health, such as the number of antenatal care visits, skilled birth attendance rates, or maternal mortality rates.

2. Data collection: Gather baseline data on the selected indicators from the target population. This can be done through surveys, interviews, or existing health records.

3. Intervention implementation: Implement the recommended interventions in the target population. This could involve training healthcare providers, establishing community health worker programs, or implementing mHealth solutions.

4. Monitoring and evaluation: Continuously monitor and evaluate the impact of the interventions on the selected indicators. This can be done through follow-up surveys, data analysis, and comparison with baseline data.

5. Data analysis: Analyze the collected data to assess the changes in the selected indicators before and after the implementation of the interventions. This will help determine the effectiveness of the recommendations in improving access to maternal health.

6. Interpretation and adaptation: Interpret the results of the data analysis and make necessary adaptations to the interventions based on the findings. This iterative process allows for continuous improvement and optimization of the interventions.

By following this methodology, it is possible to simulate the impact of the recommended innovations on improving access to maternal health and make evidence-based decisions for further implementation and scaling up of these interventions.

Partagez ceci :
Facebook
Twitter
LinkedIn
WhatsApp
Email